Mohamed A. Ahmed, Jacqueline Starrett, Isaac Hoffman, Kirk Nelson, Melissa Neal, Melissandre Pache, Emily Pettitt, Daniel Bensen, Robert Hudkins, Todd Harris, Ronald Swanson. "TYRA-430: First reversible FGFR4/3 inhibitor designed to overcome current challenges in FGF19-driven hepatocellular carcinoma treatment.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.583